SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000886163-22-000038
Filing Date
2022-04-22
Accepted
2022-04-22 16:11:27
Documents
11
Period of Report
2022-06-10

Document Format Files

Seq Description Document Type Size
1 DEF 14A ligand-2022annualmeetingpr.htm DEF 14A 1211923
2 a2021psuchart.jpg GRAPHIC 27594
3 image.jpg GRAPHIC 192798
4 image1.jpg GRAPHIC 76162
5 image2.jpg GRAPHIC 274329
6 image_0.jpg GRAPHIC 12141
7 image_2.jpg GRAPHIC 268584
8 partneredpipeline_updated.jpg GRAPHIC 315201
9 picture1.jpg GRAPHIC 106020
10 picture2.jpg GRAPHIC 105834
11 stockgraph.jpg GRAPHIC 142646
  Complete submission text file 0000886163-22-000038.txt   3284680
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33093 | Film No.: 22845613
SIC: 2834 Pharmaceutical Preparations